Zydelig (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Zydelig drug offered from Gilead Sciences, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
NON-PROPRIETARY NAME: | idelalisib |
SUBSTANCE NAME: | IDELALISIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-07-23 |
END MARKETING DATE: | 0000-00-00 |
Zydelig HUMAN PRESCRIPTION DRUG Details:
Item Description | Zydelig from Gilead Sciences, Inc. |
LABELER NAME: | Gilead Sciences, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2014-07-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61958-1701_c350baf4-c863-4255-9b90-b387b36ddc0a |
PRODUCT NDC: | 61958-1701 |
APPLICATION NUMBER: | NDA205858 |
Other IDELALISIB Pharmaceutical Manufacturers / Labelers: